Literature DB >> 30166593

Immunotherapy for advanced penile cancer - rationale and potential.

Bradley McGregor1, Guru Sonpavde2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30166593     DOI： 10.1038/s41585-018-0083-0

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  4 in total

Review 1.  Recent advances in the management of penile cancer.

Authors:  Maximilian J Johnston; Raj Nigam
Journal:  F1000Res       Date:  2019-04-26

2.  Effective combinatorial immunotherapy for penile squamous cell carcinoma.

Authors:  Tianhe Huang; Xi Cheng; Jad Chahoud; Ahmed Sarhan; Pheroze Tamboli; Priya Rao; Ming Guo; Ganiraju Manyam; Li Zhang; Yu Xiang; Leng Han; Xiaoying Shang; Pingna Deng; Yanting Luo; Xuemin Lu; Shan Feng; Magaly Martinez Ferrer; Y Alan Wang; Ronald A DePinho; Curtis A Pettaway; Xin Lu
Journal:  Nat Commun       Date:  2020-05-01       Impact factor: 14.919

3.  PD-L1 expression in anogenital and oropharyngeal squamous cell carcinomas associated with different clinicopathological features, HPV status and prognosis: a meta-analysis.

Authors:  Yuan Qin; Jiaochen Luan; Xiang Zhou; Ying Li
Journal:  Biosci Rep       Date:  2021-03-26       Impact factor: 3.840

4.  Efficacy of Applying Kanglaite Injection under Incentive Nursing Intervention in Treating Patients with Advanced Penile Carcinoma and Its Effect on Treatment Compliance.

Authors:  Juan Wang; Qingyan Liu; Mei Hong; Ge Li; Yong Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-25       Impact factor: 2.629
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.